TrialJournal of human hypertension2005

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.

M T Schram et al.PubMed ↗Publisher ↗

No numbers read from the abstract.